Health-related quality of life in patients with pancreatic cancer

Digestion

Volumn 74, Issue 2, 2007, Pages 118-125

  Muller Nordhorn J ^a   Roll, S ^a   Bohmig M ^a   Nocon, M ^a   Reich, A ^a   Braun, C ^a   Noesselt, L ^a   Wiedenmann, B ^a   Willich, S N ^a   Bruggenjurgen B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

EORTC; EQ 5D; Health related quality of life; Pancreatic cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER FATIGUE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; INSTRUMENT; LINEAR REGRESSION ANALYSIS; MALE; MEDICAL ASSESSMENT; METASTASIS; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM;

AGED; COHORT STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 33846686133     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098177     Document Type: Article

References (42)

1. Faivre J, Forman D, Esteve J, Obradovic M, Sant M: Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. Eur J Cancer 1998;34:2184-2190.
2. Du W, Touchette D, Vaitkevicius VK, Peters WP, Shields AF. Cost analysis of pancreatic carcinoma treatment. Cancer 2000;89:1917-1924.
3. Li D, Xie K, Wolff R, Abbruzzese JL: Pancreatic cancer. Lancet 2004;363:1049-1057.
4. Schmier J, Elixhauser A, Halpern MT: Health-related quality of life evaluations of gastric and pancreatic cancer. Hepatogastroenterology 1999;46:1998-2004.
5. Langenhoff BS, Krabbe PF, Wobbes T, Ruers TJ: Quality of life as an outcome measure in surgical oncology. Br J Surg 2001;88:643-652.
6. Fitzsimmons D, Johnson CD: Quality of life after treatment of pancreatic cancer. Langenbecks Arch Surg 1998;383:145-151.
7. Andreyev HJ, Norman AR, Oates J, Cunningham D: Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998;34:503-509.
8. Kelsen DP, Portenoy RK, Thaler HT, Niedzwiecki D, Passik SD, Tao Y, et al: Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 1995;13:748-755.
9. Glimelius B, Hoffman K, Sjoden PO, Jacobsson G, Sellstrom H, Enander LK, et al: Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996;7:593-600.
10. McLeod RS, Taylor BR, O'Connor BI, Greenberg GR, Jeejeebhoy KN, Royall D, et al: Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 1995;169:179-185.
11. Luman W, Cull A, Palmer KR: Quality of life in patients stented for malignant biliary obstructions. Eur J Gastroenterol Hepatol 1997;9:481-484.
12. Labori KJ, Hjermstad MJ, Wester T, Buanes T, Loge JH: Symptom profiles and palliative care in advanced pancreatic cancer - a prospective study. Support Care Cancer 2006;Epub ahead of print April 7.
13. Billings BJ, Christein JD, Harmsen WS, Harrington JR, Chari ST, Que FG, et al: Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up? J Gastrointest Surg 2005;9:1059-1066.
14. Warnick SJ Jr, Velanovich V: Correlation of patient-derived utility values and quality of life after pancreaticoduodenectomy for pancreatic cancer. J Am Coll Surg 2006;202:906-911.
15. Roberts J, Dolan P: To what extent do people prefer health states with higher values? A note on evidence from the EQ-5D valuation set. Health Econ 2004;13:733-737.
16. Müller-Nordhorn J, Brüggenjürgen B, Böhmig M, Selim D, Reich A, Noesselt L, et al: Direct and indirect costs in a prospective cohort of patients with pancreatic cancer. Aliment Pharmacol Ther 2005;22:405-415.
17. Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-343.
18. Greiner W, Claes C, Busschbach JJ, Graf von der Schulenburg JM: Validating the EQ-5D with time trade-off for the German population. Eur J Health Econ 2005;6:124-130.
19. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
20. American Joint Committee on Cancer. AJCC Cancer Staging Manual, ed 5. Philadelphia, Lippincott-Raven, 1997.
21. Dolan P: Modeling valuations for EuroQol health states. Med Care 1997;35:1095-1108.
22. König HH, Bernert S, Angermeyer MC: Health Status of the German population: results of a representative survey using the EuroQol questionnaire (in German). Gesundheitswesen 2005;67:173-182.
23. Schwarz R, Hinz A: Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001;37:1345-1351.
24. Osoba D, Rodrigues G, Myles J, Zee B, Pater J: Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139-144.
25. Benjamini Y, Hochberg Y: Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc 1995;57:289-300.
26. Homs MY, Essink-Bot ML, Borsboom GJ, Steyerberg EW, Siersema PD: Quality of life after palliative treatment for oesophageal carcinoma - a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer 2004;40:1862-1871.
27. Conner-Spady BL, Cumming C, Nabholtz JM, Jacobs P, Stewart D: A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation. Bone Marrow Transplant 2005;36:251-259.
28. Wildi SM, Cox MH, Clark LL, Turner R, Hawes RH, Hoffman BJ, et al: Assessment of health state utilities and quality of life in patients with malignant esophageal Dysphagia. Am J Gastroenterol 2004;99:1044-1049.
29. Van den Hout WB, van der Linden YM, Steenland E, Wiggenraad RG, Kievit J, de Haes H, Leer JW: Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst 2003;95:222-229.
30. Korfage IJ, Essink-Bot ML, Borsboom GJ, Madalinska JB, Kirkels WJ, Habbema JD, et al: Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer 2005;116:291-296.
31. Trippoli S, Vaiani M, Lucioni C, Messori A: Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics. Pharmacoeconomics 2001;19:855-863.
32. Conroy T, Paillot B, Francois E, Bugat R, Jacob JH, Stein U, et al: Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer - a Groupe Tumeurs Digestives of the Fédération Nationale des Centres de Lutte Contre le Cancer study. J Clin Oncol 2005;23:1228-1236.
33. Francois E, Hebbar M, Bennouna J, Mayeur D, Perrier H, Dorval E, et al: A phase II trial of raltitrexed (Tomudex) in advanced pancreatic and biliary carcinoma. Oncology 2005;68:299-305.
34. Ekstrom K, Hoffman K, Linne T, Eriksson B, Glimelius B: Single-dose etoposide in advanced pancreatic and biliary cancer, a phase II study. Oncol Rep 1998;5:931-934.
35. Halford S, Yip D, Karapetis CS, Strickland AH, Steger A, Khawaja HT, et al: A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma. Ann Oncol 2001;12:1399-1402.
36. Wenger FA, Jacobi CA, Haubold K, Zieren HU, Muller JM: Gastrointestinal quality of life after duodenopancreatectomy in pancreatic carcinoma. Preliminary results of a prospective randomized study: pancreatoduodenectomy or pylorus - preserving pancreatoduodenectomy (in German). Chirurg 1999;70:1454-1459.
37. http://www.eortc.be/home/qol/manuals.htm. European Organization of Research and Treatment of Cancer, 2006. Ref Type: Internet Communication.
38. Saltzburg D, Foley KM: Management of pain in pancreatic cancer. Surg Clin North Am 1989;69:629-649.
39. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S: The prevalence of psychological distress by cancer site. Psychooncology 2001;10:19-28.
40. Kiss A, Meryn S: Effect of sex and gender on psychosocial aspects of prostate and breast cancer. BMJ 2001;323:1055-1058.
41. Volkers N: In coping with cancer, gender matters. J Natl Cancer Inst 1999;91:1712-1714.
42. Kaasa S, Loge JH: Quality-of-life assessment in palliative care. Lancet Oncol 2002;3:175-182.